IGF1R and experimental autoimmune encephalomyelitis: Previous studies have shown that neuroinflammation could be attenuated by IGF1R inhibition in an experimental autoimmune encephalomyelitis model of multiple sclerosis [26] or Alzheimer’s disease [58–60].